The use of androgens for female sexual dysfunction

Nature Clinical Practice Urology

Volumn 3, Issue 4, 2006, Pages 176-177

  Davis, Susan R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; GESTAGEN; PSYCHOTROPIC AGENT; TESTOSTERONE;

ACNE; ADRENAL INSUFFICIENCY; AGING; ANDROGEN THERAPY; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG APPROVAL; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED PRACTICE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE ACTION; HUMAN; HYPOPITUITARISM; LIBIDO DISORDER; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; NONHUMAN; OFF LABEL DRUG USE; PATIENT SELECTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUAL SATISFACTION; WELLBEING; WOMEN'S RIGHTS;

ANDROGENS; FEMALE; HUMANS; LIBIDO; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE; WOMEN'S HEALTH;

EID: 33645774977     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0439     Document Type: Article

References (11)

1. Davison SL et al. (2005) Androgen levels in adult females: Changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 90: 3847-3853
2. Laumann EO et al. (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281: 537-544
3. Basson R et al. (2000) Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and classifications. J Urol 163: 888-893
4. Somboonporn W et al. Benefits and risks of testosterone therapy in postmenopausal women taking estrogen alone or estrogen plus progestin. The Cochrane Database of Systematic Reviews, in press.
5. Goldstat R et al. (2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10: 390-398
6. Buster JE et al. (2005) Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 105: 944-952
7. Davis SR et al. (2005) Circulating androgen levels and self-reported sexual function in women. JAMA 294: 91-96
8. Rossouw J et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
9. Somboonporn W and Davis SR (2004) Testosterone and the breast: implications for testosterone therapy for women. Endocr Rev 25: 374-388
10. Wild S et al. (2000) Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Hum Fertil (Camb) 3: 101-105
11. Misso ML et al. (2005) Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12: 210-215